Contributing Author
Michael E Thase, MD
32 articles in Psychopharmacology Bulletin
Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
Willie R. Earley, Hua Guo, György Németh, Judit Harsányi, Michael E. Thase
VOL 48 No. 4 ORIGINAL RESEARCH
Read Article Macrophage Migration Inhibitory Factor and Interleukin 1-β mRNA Levels as Predictors of Antidepressant Treatment Response in Major Depression
Henry R Kranzler, Annjanette Stone, Steven A Schichman, L Michelle Griffin, Hannah Roggenkamp, Michael E Thase, Kevin G Lynch, David W Oslin
VOL 55 No. 1 ORIGINAL RESEARCH
Read Article A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
Timothy Whitaker, Kimberly F Farrand, Michael E Thase
VOL 54 No. 1 ORIGINAL RESEARCH
Read Article Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study
Jess G Fiedorowicz, Lisa Brown, James Li, Sagar V Parikh, Boadie W Dunlop, Brent P Forester, Richard C Shelton, Michael E Thase, Matthew Macaluso, Kunbo Yu, John F Greden
VOL 51 No. 4 ORIGINAL RESEARCH
Read Article Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia)
Amnon A Berger, Emily R Sottosanti, Ariel Winnick, Joseph Keefe, Elasaf Gilbert, Jamal Hasoon, Michael E Thase, Alan D Kaye, Omar Viswanath, Ivan Urits
VOL 52 No. 1 REVIEW ARTICLE
Read Article Commentary on the Hamilton Rating Scale for Depression: 60+ Years Old and Still Relevant to the Assessment of Antidepressant Treatment Outcomes
Michael E Thase
VOL 52 No. 2 COMMENTARY
Read Article Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
Bryan Dirks, Maurizio Fava, Sarah D Atkinson, Mark Joyce, Michael E Thase, Becky Howell, Tim Lin, Serge Stankovic
VOL 52 No. 4 ORIGINAL RESEARCH
Read Article Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression
Jennifer R. Goldschmied, Arjun Sengupta, Anup Sharma, Lynne Taylor, Knashawn H. Morales, Michael E. Thase, Michael E. Thase, Aalim Weljie, Matthew S. Kayser
VOL 51 No. 3 ORIGINAL RESEARCH
Read Article Patient Response Trajectories in Major Depressive Disorder
Klaus G. Larsen, Sidney H. Kennedy, Elin Heldbo Reines, Michael E. Thase
VOL 50 No. 4 ORIGINAL RESEARCH
Read Article Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder
Charles L Bowden, Richard Priesmeyer, Mauricio Tohen, Vivek Singh, Joseph R Calabrese, Terry Ketter, Andrew Nierenberg, Michael E Thase, Gregg Siegel, Leslie H Siegel, Jim Mintz, Rif S El-Mallakh, Susan L McElroy, Melissa Martinez
VOL 51 No. 2 ORIGINAL RESEARCH
Read Article Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?
Alan G. Mallinger, Ellen Frank, Michael E.Thase, Michelle M. Barwell, Nancy DiazGranados, David A. Luckenbaugh, David J. Kupfer
VOL 42 No. 2 EVIDENCE-BASED MEDICINE
Read Article Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
Mark A. Demitrack, Michael E.Thase
VOL 42 No. 2 ORIGINAL RESEARCH
Read Article Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy
Michael E. Thase, MD
VOL 41 No. 2 EVIDENCE-BASED MEDICINE
Read Article Two New Sections Offer Further Checks And Balances: Negative And Failed Clinical Trial Reports And Invited Commentary
Michael E. Thase
VOL 40 No. 3 EDITOR’S LETTER
Read Article The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
Michael E.Thase, MD
VOL 36 No. 4 PSYCHOPHARMACOLOGY BULLETIN
Read Article Review of Its Therapeutic Utility in Depression
Joyce E. Myers, MD, and Michael E.Thase, MD
VOL 35 No. 4 GENERAL PSYCHOPHARMACOLOGY
Read Article A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
Mikael Landén, MD, PhD, and Michael E. Thase, MD
VOL 39 No. 1 GENERAL PSYCHOPHARMACOLOGY
Read Article Effects of Tranylcypromine on the Sleep of Patients with Anergic Bipolar Depression
Ripu D. Jindal, MD, Amy L. Fasiczka, MA, Jonathan M. Himmelhoch, MD, Alan G. Mallinger, MD, and Michael E. Thase, MD
VOL 37 No. 3 GENERAL PSYCHOPHARMACOLOGY
Read Article A Preliminary Open-Label Study of Moclobemide Treatment of Pain Disorder
Ripu D. Jindal, MD, Amy L. Fasiczka, MA, Jonathan M. Himmelhoch, MD, Alan G. Mallinger, MD, and Michael E. Thase, MD
VOL 37 No. 3 GENERAL PSYCHOPHARMACOLOGY
Read Article Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
Jodi M. Gonzalez, PhD, Peter Thompson, MD, Michael Escamilla, MD, Mako Araga, MS, Vivek Singh, MD, Niamh Farrelly, MD, Michael E. Thase, MD, David J. Miklowitz, PhD, and Charles L. Bowden, MD
VOL 40 No. 1 ORIGINAL RESEARCH
Read Article Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide
Mark S. Bauer, MD, Stephen R. Wisniewski, PhD, Jane N. Kogan, PhD, Lauren B. Marangell, MD, Michael E. Thase, MD, Gary Sachs, MD, for the STEP-BD Investigators
VOL 39 No. 1 ORIGINAL RESEARCH
Read Article Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients
Mark S. Bauer, MD, Stephen R. Wisniewski, PhD, Jane N. Kogan, PhD, Lauren B. Marangell, MD, Michael E. Thase, MD, Gary Sachs, MD, for the STEP-BD Investigators
VOL 39 No. 1 EVIDENCE-BASED MEDICINE
Read Article Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
Robert MA Hirschfeld, MD, Joseph R. Calabrese, MD, Mark A. Frye, MD, Philip W. Lavori, PhD, Gary Sachs, MD, Michael E. Thase, MD, and Karen Dineen Wagner, MD, PhD
VOL 40 No. 3 ORIGINAL RESEARCH
Read Article Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study
Anthony J. Rothschild, Boadie W. Dunlop, David L. Dunner, Edward S. Friedman, Alan Gelenberg, Peter Holland, James H. Kocsis, Susan G. Kornstein, Richard Shelton, Madhukar H. Trivedi, John M. Zajecka, Corey Goldstein, Michael E. Thase, Ron Pedersen, Martin B. Keller
VOL 42 No. 3 ORIGINAL RESEARCH
Read Article A Systematic Review of Augmentation Strategies for Patients with Major Depressive Disorder
Rachael Fleurence, Rebecca Williamson, Yonghua Jing, Edward Kim, Quynh-Van Tran, Andrei Pikalov, Michael E. Thase
VOL 42 No. 3 GENERAL PSYCHIATRY
Read Article Correlates of Functioning in Bipolar Disorder
Laszlo Gyulai, Mark S. Bauer, Lauren B. Marangell, Ellen B. Dennehy, Michael E. Thase, Michael W. Otto, Hongwei Zhang, Stephen R. Wisniewski, David J. Miklowitz, Mark H. Rapaport, Claudia F. Baldassano, and Gary S. Sachs for the STEP-BD Investigators
VOL 41 No. 4 EVIDENCE-BASED MEDICINE
Read Article REVAMP – Research Evaluating the Value of Augmenting Medication with Psychotherapy: Rationale and Design
Madhukar H. Trivedi, James H. Kocsis, Michael E. Thase, David W. Morris, Stephen R. Wisniewski, Andrew C. Leon, Alan J. Gelenberg, Daniel N. Klein, George Niederehe, Alan F. Schatzberg, Philip T. Ninan, Martin B. Keller
VOL 41 No. 4 ORIGINAL RESEARCH
Read Article Gender-Specific Differences in Depression and Treatment Response
Susan G. Kornstein, MD, Diane M. E. Sloan, PharmD, and Michael E. Thase, MD
Remission as the Critical Outcome of Depression Treatment
Michael E. Thase, MD, Diane M. E. Sloan, PharmD, and Susan G. Kornstein, MD
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
Michael E. Thase, MD; and Madhukar Trivedi, MD
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
Michael E. Thase, MD; and Philip T. Ninan, MD